syndrome, 1986–1991. Am J Ment Retard 1996; 100:643.
130 130. Wu J, Morris JK. The population prevalence of Down's syndrome in England and Wales in 2011. Eur J Hum Genet 2013; 21:1016.
131 131. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population‐based study. Lancet 2002; 359:1019.
132 132. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukemia and solid tumours in individuals with Down's syndrome. Lancet 2000; 355:165.
133 133. Roizen NJ, Patterson D. Down's syndrome. Lancet 2003; 361:1281.
134 134. Matsunaga S, Imakiire T, Koga H, et al. Occult spinal canal stenosis due to C‐1 hypoplasia in children with Down syndrome. J Neurosurg 2007; 107:457.
135 135. Anwar AJ, Walker JD, Frier BM. Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabet Med 1998; 15:160.
136 136. Menéndez M. Down syndrome, Alzheimer's disease and seizures. Brain Dev 2005; 27:246.
137 137. Patja K, Pukkala E, Sund R, et al. Cancer incidence of persons with Down syndrome in Finland: a population‐based study. Int J Cancer 2006; 118:1769.
138 138. Hill DA, Gridley G, Cnattingius S, et al. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 2003; 163:705.
139 139. Malt EA, Dahl RC, Haugsand TM, et al. Health and disease in adults with Down syndrome. Tidsskr Nor Laegeforen 2013; 133:290.
140 140. Kosashvili Y, Taylor D, Backstein D, et al. Total hip arthroplasty in patients with Down syndrome. Orthopedics 2010; 33:629.
141 141. Weijerman ME, de Winter JP. The care of children with Down syndrome. Eur J Pediatr 2010; 169:1445.
142 142. Kobayashi T, Sakemi Y, Yamashita H. Increased incidence of retroperitoneal teratomas and decreased incidence of sacrococcygeal teratomas in infants with Down syndrome. Pediatr Blood Cancer 2014; 61:363.
143 143. De Simone R, Puig XS, Gélisse P, et al. Senile myoclonic epilepsy: delineation of a common condition associated with Alzheimer's disease in Down syndrome. Seizure 2010; 19:383.
144 144. Tenenbaum A, Chavkin M, Wexler I, et al. Morbidity and hospitalizations of adults with Down syndrome. Res Dev Disabil 2012; 33:435.
145 145. Mårlid K, Stephansson O, Grahnquist L, et al. Down syndrome is associated with elevated risk of celiac disease: a nationwide case‐control study. J Pediatr 2013; 163:237.
146 146. Satgé D, Sasco AJ, Day S, et al. A lower risk of dying from urological cancer in Down syndrome: clue for cancer protecting genes on chromosome 21. Urol Int 2009; 82:296.
147 147. Hasle H, Friedman JM, Olsen JH, et al. Low risk of solid tumors in persons with Down syndrome. Genet Med 2016; 18(11):1151.
148 148. Määttä T, Määttä J, Tervo‐Määttä T, et al. Healthcare and guidelines: a population based survey of recorded medical problems and health surveillance for people with Down syndrome. J Intellect Dev Disabil 2011; 36:118.
149 149. de Carvalho M, Swash M. Neurologic complications of craniovertebral dislocation. Handb Clin Neurol 2014; 119:435.
150 150. Hithersay R, Startin CM, Hamburg S, et al. Association of dementia with mortality among adults with Down syndrome older than 35 years. JAMA Neurol 2019; 76:152.
151 151. Satgé D, Seidel MG. The pattern of malignancies in Down syndrome and its potential context with the immune system. Front Immunol 2018; 9:3058.
152 152. Morris JK, Garne E, Wellesley D, et al. Major congenital anomalies in babies born with Down syndrome: a EUROCAT population‐based registry study. Am J Med Genet 2014; 164A:2979.
153 153. Ghezzo A, Salvioli S, Solimando MC, et al. Age related changes of adaptive and neuropsychological features in persons with Down syndrome. PLoS One 2014; 9:e113111.
154 154. Hartley D, Blumenthal T, Carrillo M, et al. Down syndrome and Alzheimer's disease: common pathways, common goals. Alzheimers Dement 2015; 11:700.
155 155. Kinnear D, Morrison J, Allan L, et al. Prevalence of physical conditions and multimorbidity in a cohort of adults with intellectual disabilities with and without Down syndrome: cross‐sectional study. BMJ Open 2018; 8:e018292.
156 156. Ludvigsson JF, Lebwohl B, Green PHR, et al. Celiac disease and Down syndrome mortality: a nationwide cohort study. BMC Pediatr 2017; 17:41.
157 157. Oxelgren UW, Myrelid A, Annerén G, et al. Prevalence of autism and attention‐deficit‐hyperactivity disorder in Down syndrome: a population‐based study. Dev Med Child Neurol 2017; 59:276.
158 158. Palaska PK, Antonarakis GS. Prevalence and patterns of permanent tooth agenesis in individuals with Down syndrome: a meta‐analysis. Eur J Oral Sci 2016; 124:317.
159 159. Santoro SL, Cannon S, Capone G, et al. Unexplained regression in Down syndrome: 35 cases from an international Down syndrome database. Genet Med 2020; 22(4):767.
160 160. Cuoghi OA, Topolski F, de Faria LP, et al. Prevalence of dental anomalies in permanent dentition of Brazilian individuals with Down syndrome. Open Dent J 2016; 10:469.
161 161. Garg A, Strunk A, Midura M, et al. Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population‐based cross‐sectional analysis. Br J Dermatol 2018; 178:697.
162 162. Giménez S, Videla L, Romero S, et al. Prevalence of sleep disorders in adults with Down syndrome: a comparative study of self‐reported, actigraphic, and polysomnographic findings. J Clin Sleep Med 2018; 14:1725.
163 163. Hamilton J, Yaneza MMC, Clement WA, et al. The prevalence of airway problems in children with Down's syndrome. Int J Pediatr Otorhinolaryngol 2016; 81:1.
164 164. Sinai A, Mokrysz C, Bernal J, et al. Predictors of age of diagnosis and survival of Alzheimer's disease in Down syndrome. J Alzheimers Dis 2018; 61:717.
165 165. Whooten R, Schmitt J, Schwartz A. Endocrine manifestations of Down syndrome. Curr Opin Endocrinol Diabetes Obes 2018; 25:61.
166 166. Sheets KB, Crissman BG, Feist CD, et al. Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: recommendations of the National Society of Genetic Counselors. J Genet Counsel 2011; 20:432.
167 167. Milunsky A. The prenatal diagnosis of hereditary disorders. Springfield, IL: Charles C. Thomas, 1973.
168 168. American Society for Reproductive Medicine, American College of Obstetricians and Gynecologists' Committee on Gynecologic Practice. Prepregnancy counseling: Committee Opinion No. 762. Fertil Steril 2019; 111:32.
169 169. American College of Obstetricians and Gynecologists. Family history as a risk assessment tool. Obstet Gynecol 2011; 117:747.
170 170. Wilson RD. Genetic considerations for a woman's preconception evaluation. J Obstet Gynaecol Can 2011; 33:57.
171 171. Rubin SP, Malin J, Maidman J. Genetic counseling before prenatal diagnosis for advanced maternal age: an important medical safeguard. Obstet Gynecol 1983; 62:155.
172 172. Kessler S. Psychological aspects of genetic counseling. XIII. Empathy and decency. J Genet Couns 1999; 8:333.
173 173. Scheiper S, Ramos‐Luis E, Blanco‐Verea A, et al. Sudden unexpected death in the young – value of massive parallel sequencing in postmorten genetic analyses. Forensic Sci Int 2018; 293:70.
174 174. Spoonamore KG, Ware SM. Genetic testing and genetic counseling in patients with sudden death risk due to heritable arrhythmias. Heart Rhythm 2019; 13:789.
175 175. Tang Y, Williams N, Sampson BA. Genetic testing in sudden unexpected natural death in the young: New York City Office of Chief Medical Examiner's experience and perspective. Forensic Sci Med Pathol 2019; 15:481.
176 176. Tester DJ, Ackerman MJ. Evaluating the survivor or the relatives of those who do not survive: the role of genetic testing. Cardiol Young 2017; 27:S19.
177 177. Tejada MI, Ibarluzea N. Non‐syndromic X‐linked intellectual disability: